Clik here to view.
NICEのガイダンスは患者の安定胸痛の原因判定に役立てるようHeartFlow FFRct Analysisを推奨
米カリフォルニア州レッドウッドシティー （ビジネスワイヤ） — 英国立医療技術評価機構（NICE）は本日、患者の安定胸痛の原因判定に役立てるよう、HeartFlow® FFRct Analysis使用のガイダンスを発出しました。ハートフローが開発したHeartFlow FFRct...
View ArticleClik here to view.
Solasia and Lee’s Pharma Announce License, Promotion and Supply Agreement...
TOKYO & HONG KONG Solasia Pharma K.K. (Headquarters: Tokyo, Japan, President: Yoshihiro Arai, hereinafter “Solasia”) and Lee’s Pharmaceutical Holdings Limited (hereinafter “Lee’s Pharma”)(SEHK...
View ArticleClik here to view.
Masimo宣布其MightySat™ Rx测量呼吸率获得CE标记
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，根据MightySat™ Rx指尖脉搏氧饱和度仪上的血氧容积描记波(RRpTM)测量呼吸率已获得CE标记。MightySat Rx是一款无创仪器，可测量和显示功能性氧饱和度(SpO2)、脉率(PR)和灌注指数(PI)，可添加脉搏灌注变异指数(PVi®)选项，现在可添加RRp选项。 Smart News...
View ArticleClik here to view.
Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term...
OSAKA, Japan & LEUVEN, Belgium Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq:TIG) (“TiGenix”) today announced new data from the Phase 3...
View ArticleClik here to view.
Health Canada Approves Otsuka and Lundbeck’s REXULTI™ (brexpiprazole) as a...
TOKYO & MONTREAL Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI™ (brexpiprazole) for the treatment of...
View ArticleClik here to view.
ミネルヴァ・バイオテクノロジーズがナイーブ型幹細胞培養システムのAlphaSTEM™を発売
米マサチューセッツ州ウォルサム （ビジネスワイヤ） — がん治療および再生医療の分野における一流企業のミネルヴァ・バイオテクノロジーズは本日、AlphaSTEM™培養システムの市場投入を発表しました。このシステムは、胚形成の最初期に内部細胞塊のナイーブ細胞内のみで発現する新発見の成長因子を使用しています。...
View ArticleClik here to view.
マシモ、MightySat™ Rxによる呼吸数測定でCEマークを取得と発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、フィンガーチップパルスオキシメーターMightySat™ Rxで脈波からの呼吸数（RRpTM）を測定する機能がCEマークを取得したと発表しました。MightySat...
View ArticleClik here to view.
EP Vantage Releases its Annual Pharma and Medtech Sector Review Reports for 2016
LONDON, BOSTON, SAN FRANCISCO & TOKYO For the world’s drug makers 2016 was a year of two halves. Dealmaking and venture funding held up over the first two quarters, buoyed by the retreating bull...
View ArticleClik here to view.
Initial Results Positive for CelGro® in Human Nerve Regeneration
PERTH, Australia Regenerative medicine company Orthocell is pleased to announce positive initial safety and tolerability results for its CelGro® collagen-based medical device, in a clinical study...
View ArticleClik here to view.
Truxima™, the first biosimilar mAb in oncology, granted EU marketing...
INCHEON, South Korea Celltrion Healthcare today announced that the European Commission has approved Truxima™ (biosimilar rituximab) for all indications of reference rituximab in the European Union...
View ArticleClik here to view.
Origin, Arcadia Announce China Biotechnology Collaboration in Corn
DES MOINES, Iowa & DAVIS, Calif. Origin (Origin Agritech, LLC, a subsidiary of Origin Agritech Ltd., NASDAQ: SEED), an agricultural biotechnology trait and seed provider, and Arcadia (Arcadia...
View ArticleClik here to view.
サンバイオの脳梗塞に対する幹細胞治療が米国心臓協会からイノベーション・アワードを受賞
米カリフォルニア州マウンテンビュー （ビジネスワイヤ） — 神経系疾患を対象に再生細胞薬の開発・製造を手掛ける当社グループ（サンバイオ株式会社及びその子会社であるSanBio, Inc.） は、米国心臓協会（American Heart Association）の発行する医療専門誌Strokeで論文発表された骨髄由来間葉系幹細胞を使った脳梗塞治験フェーズ1/2a（本試験）について、2016...
View ArticleClik here to view.
Study of SanBio’s Stem Cell Treatment for Stroke Receives Innovation Award...
MOUNTAIN VIEW, Calif. SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, today announced that a recent publication of its novel stem cell treatment, SB623, for...
View ArticleClik here to view.
Waters Honors Singapore’s Bioprocessing Technology Institute (BTI) for...
MILFORD, Mass. At a ceremony and symposium today, Waters Corporation (NYSE:WAT) welcomed into its Centers of Innovation Program the Bioprocessing Technology Institute (BTI), a research institute...
View ArticleClik here to view.
joimax® Obtains Full Product Registration in Thailand, and is Now Active in...
IRVINE, Calif. joimax® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding...
View ArticleClik here to view.
Evaluate: Median Cost Per Patient for Orphan Drugs is 5.5 Times Higher Than...
LONDON, BOSTON & TOKYO The steady and inexorable growth of the orphan drug market remains one of the prominent themes in the fourth edition of the EvaluatePharma Orphan Drug Report 2017. What...
View ArticleClik here to view.
Baxter and ScinoPharm Announce Exclusive Strategic Partnership for Generic...
DEERFIELD, Ill. & TAINAN, Taiwan Baxter International Inc. (NYSE: BAX) and ScinoPharm Taiwan, Ltd. (TWSE: 1789) today announced a strategic partnership to develop, manufacture and commercialize...
View ArticleClik here to view.
Pharmaron Acquires Majority Stake in SNBL CPC
BEIJING Pharmaron, a fully integrated contract research organization offering R&D services to the life sciences industry, today announced that it has signed a definitive agreement under which...
View ArticleClik here to view.
Invenra and QIMR Berghofer Medical Research Institute Enter Collaboration to...
MADISON, Wis. & HERSTON, Australia Invenra, Inc., a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies, bispecifics and antibody derivatives,...
View ArticleClik here to view.
US Medical Device Company Visioneering Technologies, Inc. to List On ASX –...
ALPHARETTA, Georgia Visioneering Technologies, Inc. (VTI), a US based medical device company, is pleased to announce the opening of its fully underwritten Initial Public Offering (IPO) to raise...
View Article